Maxime Dely: How Plasma Exchange Treats Severe Diseases – “A Simple Act Behind a Complex Therapy”
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Plasma: the invisible therapy that’s already transforming modern medicine!
Plasma exchanges play a crucial role today in treating many severe conditions. Performed using apheresis, they remove harmful components from the patient’s plasma… a highly technical procedure with often remarkable results.
And for this therapy to exist, one key element is essential: albumin.
A protein available exclusively thanks to plasma donations. Without donors, plasma exchanges simply cannot happen.
A major therapeutic tool
Plasma exchanges are used to treat:
• Autoimmune diseases (myasthenia gravis, Guillain-Barré syndrome…)
• Hematological disorders
• Severe neurological conditions
• Kidney diseases
• Complex immunological disorders
This technique removes autoantibodies, toxins or immune complexes that drive the disease.
Looking ahead: incredible new prospects
Recent studies suggest that plasma exchanges may slow the progression of Alzheimer’s disease, opening the door to new approaches for neurodegenerative conditions.
A promising field that could reshape the future of care for millions of patients.
A simple act behind a complex therapy
Plasma exchanges require large amounts of albumin.
Albumin comes only from plasma donors.
Every donation makes these treatments possible.
A heartfelt thank you to all donors: your generosity saves lives every single day.”

Get the latest from Hemostasis Today.
-
Dec 10, 2025, 14:57Elvira Grandone Announces the 1st ThrombUS+ Data Challenge
-
Dec 10, 2025, 14:18Love Preet Kalra on A Paradigm Shift in ICH
-
Dec 10, 2025, 13:37Aakanksha A: A Highlight of the Week Was Presenting Our ASH Poster
-
Dec 9, 2025, 23:37Thomas Reiser: Renew Your ISTH Membership for 2025
-
Dec 9, 2025, 23:23Rahul Bhargava: Late-Breaking ASH 2025 Highlight
-
Dec 9, 2025, 13:34Aimn Abdujawad and Collaegues: A Quality Improvement Project to Optimize IVC Filter Use and Retrieval and Other More Projects at the ASH
-
Dec 9, 2025, 13:32Priya Prasad: A Night in the ER – When a Snakebite Teaches You the Power of Viscoelastic Testing
-
Dec 9, 2025, 13:27Riten Kumar: Highlights From Day 2 of ASH25
-
Dec 9, 2025, 13:25Dr. Abdul Muqtadir Abbasi: The Effect of Recombinant Factor VIIa Treatment in Non-Traumatic Intracranial Hemorrhage
